---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-309853"
form_type: "8-K"
ticker: "HURA"
cik: "0001498382"
company_name: "TuHURA Biosciences, Inc./NV"
filed_at: "2025-12-05T23:59:59+00:00"
generated_at: "2026-05-16T14:14:05.703084+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# TuHURA draws additional $1.5M under amended loan; total $3M, issues warrants

## Summary
- Borrowed an additional $1.5M on Dec 2, 2025, bringing aggregate loans to $3.0M under the Loan Agreement.
- Amendment extends availability period to Dec 5, 2025 and sets warrants at 150K shares per $1.5M borrowed.
- Issued warrant to purchase 234,783 shares at $1.81/share, expiring in two years.
- Lender is Matthew Nachtrab Revocable Trust; warrants cover both the initial and second loan advances.

## SEC filing metadata
- accession: 0001193125-25-309853
- form_type: 8-K
- ticker: HURA
- cik: 0001498382
- company_name: TuHURA Biosciences, Inc./NV
- filed_at: 2025-12-05T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1498382/000119312525309853/0001193125-25-309853-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1498382/000119312525309853/hura-20251202.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-309853
- JSON: https://secwatch.observer/filing/0001193125-25-309853.json
- Plain text: https://secwatch.observer/filing/0001193125-25-309853.txt

## Key facts
- Debt Financings
  TuHURA Biosciences, Inc./NV incurred loan of $1.5 million with Matthew Nachtrab Revocable Trust dated 12/18/2014.
  - Instrument: loan
  - Principal: $1.5 million
  - Counterparty: Matthew Nachtrab Revocable Trust dated 12/18/2014
  - Event: incurrence
  source text: the Company borrowed an additional $1.5 million from the Lender under the Loan Agreement (the “Second Loan”), which resulted in aggregate Loans of $3.0 million made to the Company under the Loan Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1498382/000119312525309853/0001193125-25-309853-index.htm
- Debt Financings
  TuHURA Biosciences, Inc./NV amended loan with Matthew Nachtrab Revocable Trust dated 12/18/2014.
  - Instrument: loan
  - Counterparty: Matthew Nachtrab Revocable Trust dated 12/18/2014
  - Event: amendment
  source text: (the “Company”) on October 31, 2025, the Company previously entered into a Secured Promissory Note and Loan Agreement, dated October 27, 2025 (the “Loan Agreement”), with the Matthew Nachtrab Revocable Trust dated 12/18/2014 (the “Lender”). Pursuant to the terms of the Loan Agreement, the Lender agreed to make loans to the Company in an aggregate principal amount of up to $3.0 million (the “Loans”) during a 30-day availability period beginning on the date of the Loan Agreement (the “Availability Period”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1498382/000119312525309853/0001193125-25-309853-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.